About Macrogen
Macrogen is a company based in Seoul (South Korea) founded in 1997 by Jeong Sun Seo. The company has 529 employees as of December 31, 2024. Macrogen operates in a competitive market with competitors including Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
- Headquarter Seoul, South Korea
- Employees 529 as on 31 Dec, 2024
- Founders Jeong Sun Seo
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Macrogen, Inc.
-
Annual Revenue
$92.06 M (USD)2.24as on Dec 31, 2024
-
Net Profit
-$5.15 M (USD)54.78as on Dec 31, 2024
-
EBITDA
$2.92 M (USD)-59.04as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
529
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Macrogen
Macrogen is a publicly listed company on the KRX with ticker symbol 038290 in South Korea, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Macrogen
Unlock access to complete
Unlock access to complete
Funding Insights of Macrogen
Detailed funding history for Macrogen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Macrogen
Investment portfolio details for Macrogen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Macrogen
Detailed financials for Macrogen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Macrogen Comparisons
Peer comparison for Macrogen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Macrogen
Macrogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejuvenate Bio, Novogene Corporation, Clinical Microbiomics, BGI and Genewiz, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of Macrogen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Macrogen
Complete news archive for Macrogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Macrogen
Macrogen was founded in 1997.
Macrogen is headquartered in Seoul, South Korea.
Hyonyong Chong is the current CEO of Macrogen.
As of Dec 31, 2024, the latest employee count at Macrogen is 529.
Annual revenue of Macrogen is $92.06M as on Dec 31, 2024.
Macrogen was founded in 1997 in Seoul, South Korea, and operates in the genomics sector. A platform for next-generation sequencing is offered, along with services such as data analysis, capillary sequencing, microarray analysis using chips from Illumina, Affymetrix, and Agilent, oligonucleotide synthesis, and data analytics. Custom transgenic mice and knockout mouse models are also developed for research purposes.
Macrogen's top competitors include Novogene Corporation, BGI and Source BioScience.
Yes, Macrogen is publicly traded on KRX under the ticker symbol 038290.
The ticker symbol of Macrogen is 038290 on KRX.